Intercept Pharmaceuticals
Intercept Pharmaceuticals: signs a material agreement, completes an acquisition or sale of assets and 7 other items
- Form
- 8-K
- Filed
- Period
- Importance
- Major
- Accession
- 0001104659-23-115782
- Document
- 8-K
- Exhibit 4.1
- Warrants or notes
- Exhibit 4.2
- Warrants or notes
- Exhibit 99.1
- Press release
- Signs a material agreement (1.01)
- Completes an acquisition or sale of assets (2.01)
- Says a debt obligation was accelerated (2.04)
- Reports an exchange listing deficiency notice (3.01)
- Changes shareholder rights (3.03)
- Reports a change in control (5.01)
- Reports an executive or board change (5.02)
- Amends its charter or bylaws (5.03)
- Discloses other events (8.01)
Not explained yet; the original is on EDGAR.
Similar companies
Same SIC code (2834) and public float not reported.